Zero Gravity Solutions, Inc. Announces Appointment of Andrew E. Koopman as President and Chief Executive Officer of Zero Gravity Life Sciences, Inc.
BOCA RATON, Fla.— (July 13, 2016),– Zero Gravity Solutions, Inc. (“ZGSI” or the “Company”) (Pink Sheets: ZGSI), an agricultural biotechnology public company commercializing its technology derived from and designed for Space with significant applications for agriculture on Earth, announced that Andrew E. Koopman has been appointed President and Chief Executive Officer of Zero Gravity Life Sciences, Inc. (ZGLS). ZGLS, a wholly-owned subsidiary of ZGSI, is focused on expanding the Company’s intellectual property related to life sciences. The IP was developed from research conducted on the International Space Station enabled by six NASA missions.
Mr. Koopman’s initial focus is to coordinate the activities of the Company’s expanded scientific team, including our research activities with NASA Ames under the previously announced Space Act Agreement. Mr. Koopman’s responsibilities also include technical support and research to diversify the BAM-FX™ product line, grant and IP strategies and execution.
“Andrew’s background as Director of New Ventures at New York University’s (NYU) Office of Industrial Liaison provides our Company with the unique skill sets required to develop intellectual property into successful commercial business opportunities,” stated Harvey Kaye, ZGSI’s Chairman of the Board.
“After serving as a Scientific Advisor for Zero Gravity Solutions for the previous two years and observing the progress made in development and commercialization of the BAM-FX™ technology, I am excited to join such an extraordinary team. I look forward to leveraging my relationships and applying my experience in the translation of scientific achievements and intellectual property as contribution towards both the achievement of ZGSI’s critical mission and the enhancement of shareholder value”, stated Andrew Koopman, ZGLS’s new President and Chief Executive Officer.
Zero Gravity Solutions, Inc. Closes Final Tranche of its Equity Private Placement, Raising a Total of $6.25 Million
BOCA RATON, Fla.— (May 24, 2016),– Zero Gravity Solutions, Inc.'s ("ZGSI" or the "Company") (Pink Sheets: ZGSI), an agricultural biotechnology public company commercializing its technology derived from and designed for Space with significant applications for agriculture on Earth, announced that it has closed the final tranche of its previously announced offering of the Company's Units in an exempt private placement transaction ("Private Placement"). Each Unit in the Private Placement consisted of one share of common stock and a warrant to purchase one share of common stock. The Company received gross proceeds of $6,260,000 million pursuant to the Private Placement.
Livingston Securities, LLC acted as the placement agent for the Private Placement. The proceeds from this Private Placement will provide the capital to deploy the infrastructure necessary to support the rollout of the Company's first commercial product, BAM-FX, in agricultural markets.
"The capital raise has allowed the Company to expand its field staff, including certified crop advisors, agronomists and qualified sales and marketing personnel to accelerate sales and customer support as we rollout BAM-FX to both domestic and international agricultural markets. We have also enhanced our production facility capabilities to service the growing needs of our now expanding customer base," stated Glenn Stinebaugh, ZGSI's President and Chief Executive Officer.
For more details on the Private Placement, please refer to the Company's recent US Securities and Exchange Commission filing.
The Units, common stock and warrants, and any other securities offered in the Private Placement or any other securities to be offered in any proposed future private placement (collectively, the "Securities") have not been registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any other jurisdiction. Because the Securities are not registered, the Securities may not be offered or sold in the United States absent registration or an exemption from registration. This press release is being issued pursuant to and in accordance with Rule 135c under the Securities Act and shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities, nor shall there be any sales of the securities mentioned in this press release in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.